References
- Alvir JMJ, Lieberman JA, Safferman AZ, Schwimmer JL, Schaaf JA. 1993. Clozapine-induced agranulocytosis–incidence and risk factors in the United States. N Engl J Med. 329(3):162–167. doi:10.1056/NEJM199307153290303
- Citrome L, McEvoy JP, Saklad SR. 2016. Guide to the management of clozapine-related tolerability and safety concerns. Clin Schizophrenia Relate Psychoses. 10(3):163–177. doi:10.3371/1935-1232.10.3.163
- Ellis P, Harrison-Woolrych M, McLean R. 2006. Clozapine - fatal constipation more common than fatal agranulocytosis. Acta Neuropsychiatr. 18(6):285–285. doi:10.1017/S0924270800031148
- Every-Palmer S, Newton‐Howes G, Clarke MJ. 2017. Pharmacological treatment for antipsychotic‐related constipation. Cochrane Database Sys Rev. 1:CD011128.
- Every-Palmer S, Nowitz M, Stanley J, Grant E, Huthwaite M, Dunn H, Ellis PM. 2016. Clozapine-treated patients have marked gastrointestinal hypomotility, the probable basis of life-threatening gastrointestinal complications: a cross sectional study. EBioMedicine. 5:125–134. doi:10.1016/j.ebiom.2016.02.020
- Flanagan RJ, Ball RY. 2011. Gastrointestinal hypomotility: an under-recognised life-threatening adverse. ef fect of clozapine. Forensic Sci Int. 206(1–3):e31–e36. doi:10.1016/j.forsciint.2010.07.021
- Haas S J, Hill R, Krum H, Liew D, Tonkin A, Demos L, Stephan K, McNeil J. 2007. Clozapine-associated myocarditis. Drug Safety. 30(1):47–57. doi:10.2165/00002018-200730010-00005
- Hibbard KR, Propst A, Frank DE, Wyse J. 2009. Fatalities associated with clozapine-related constipation and bowel obstruction: a literature review and two case reports. Psychosomatics. 50(4):416–419. doi:10.1176/appi.psy.50.4.416
- Levin TT, Barrett J, Mendelowitz A. 2002. Death from clozapine-induced constipation: case report and literature review. Psychosomatics. 43(1):71–73. doi:10.1176/appi.psy.43.1.71
- Medicines and Health Products Regulatory Agency. 2017. Clozapine: reminder of potentially fatal risk of intestinal obstruction, faecal impaction, and paralytic ileus. Drug Safety Update. 11(3):4.
- Meltzer HY. 1992. Treatment of the neuroleptic-nonresponsive schizophrenic patient. Schizophrenia Bull. 18(3):515–542. doi:10.1093/schbul/18.3.515
- Palmer SE, McLean RM, Ellis PM, Harrison-Woolrych M. 2008. Life-threatening clozapine-induced gastrointestinal hypomotility: an analysis of 102 cases. J Clin Psychiatr. 69(5):759–768. doi:10.4088/JCP.v69n0509
- West S, Rowbotham D, Xiong G, Kenedi C. 2017. Clozapine induced gastrointestinal hypomotility: a potentially life threatening adverse event. A review of the literature. General Hospital Psychiatr. 46:32–37. doi:10.1016/j.genhosppsych.2017.02.004